vs
凯勒威廉姆斯（CTO）与KESTRA MEDICAL TECHNOLOGIES, LTD.（KMTS）财务数据对比。点击上方公司名可切换其他公司
凯勒威廉姆斯的季度营收约是KESTRA MEDICAL TECHNOLOGIES, LTD.的1.8倍（$41.2M vs $22.6M），凯勒威廉姆斯净利率更高（15.1% vs -145.3%，领先160.4%）
凯勒威廉姆斯地产是一家美国科技企业及跨国房地产特许经营商，总部位于得克萨斯州奥斯汀。截至2022年，按销售额计算，它是美国规模最大的房地产特许经营机构，业务覆盖全球多个地区。
Kestra Medical Technologies（KMTS）是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业，核心产品覆盖介入心脏病学与结构性心脏病治疗领域，市场覆盖北美、欧洲及亚太重点区域，服务全球医疗机构与患者。
CTO vs KMTS — 直观对比
营收规模更大
CTO
是对方的1.8倍
$22.6M
净利率更高
CTO
高出160.4%
-145.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $41.2M | $22.6M |
| 净利润 | $6.2M | $-32.8M |
| 毛利率 | — | 50.6% |
| 营业利润率 | 175.0% | -140.7% |
| 净利率 | 15.1% | -145.3% |
| 营收同比 | 15.0% | — |
| 净利润同比 | 174.4% | — |
| 每股收益（稀释后） | $0.13 | $-0.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTOKMTS
| Q1 26 | $41.2M | — | ||
| Q4 25 | $38.3M | $22.6M | ||
| Q3 25 | $37.8M | $19.4M | ||
| Q2 25 | $37.6M | — | ||
| Q1 25 | $35.8M | — | ||
| Q4 24 | $35.7M | — | ||
| Q3 24 | $31.8M | — | ||
| Q2 24 | $28.8M | — |
净利润CTOKMTS
| Q1 26 | $6.2M | — | ||
| Q4 25 | $28.3M | $-32.8M | ||
| Q3 25 | $2.9M | $-25.8M | ||
| Q2 25 | $-23.4M | — | ||
| Q1 25 | $2.3M | — | ||
| Q4 24 | $-15.2M | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $1.2M | — |
毛利率CTOKMTS
| Q1 26 | — | — | ||
| Q4 25 | 75.0% | 50.6% | ||
| Q3 25 | 75.4% | 45.7% | ||
| Q2 25 | 73.0% | — | ||
| Q1 25 | 75.2% | — | ||
| Q4 24 | 74.4% | — | ||
| Q3 24 | 74.4% | — | ||
| Q2 24 | 71.1% | — |
营业利润率CTOKMTS
| Q1 26 | 175.0% | — | ||
| Q4 25 | 75.1% | -140.7% | ||
| Q3 25 | 26.6% | -149.1% | ||
| Q2 25 | -33.7% | — | ||
| Q1 25 | 22.0% | — | ||
| Q4 24 | -20.4% | — | ||
| Q3 24 | 15.6% | — | ||
| Q2 24 | 18.8% | — |
净利率CTOKMTS
| Q1 26 | 15.1% | — | ||
| Q4 25 | 73.9% | -145.3% | ||
| Q3 25 | 7.7% | -133.3% | ||
| Q2 25 | -62.2% | — | ||
| Q1 25 | 6.3% | — | ||
| Q4 24 | -42.6% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 4.1% | — |
每股收益（稀释后）CTOKMTS
| Q1 26 | $0.13 | — | ||
| Q4 25 | $0.81 | $-0.64 | ||
| Q3 25 | $0.03 | $-0.50 | ||
| Q2 25 | $-0.77 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | $-0.69 | — | ||
| Q3 24 | $0.17 | — | ||
| Q2 24 | $-0.03 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.3M | $175.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $575.4M | $164.1M |
| 总资产 | $1.3B | $246.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTOKMTS
| Q1 26 | $8.3M | — | ||
| Q4 25 | $6.5M | $175.4M | ||
| Q3 25 | $9.3M | $201.2M | ||
| Q2 25 | $8.6M | — | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $8.2M | — | ||
| Q2 24 | $4.8M | — |
总债务CTOKMTS
| Q1 26 | — | — | ||
| Q4 25 | $616.3M | — | ||
| Q3 25 | $604.2M | — | ||
| Q2 25 | $605.4M | — | ||
| Q1 25 | $602.2M | — | ||
| Q4 24 | $519.0M | — | ||
| Q3 24 | $526.8M | — | ||
| Q2 24 | $482.7M | — |
股东权益CTOKMTS
| Q1 26 | $575.4M | — | ||
| Q4 25 | $567.3M | $164.1M | ||
| Q3 25 | $557.3M | $184.2M | ||
| Q2 25 | $574.1M | — | ||
| Q1 25 | $593.9M | — | ||
| Q4 24 | $612.8M | — | ||
| Q3 24 | $595.8M | — | ||
| Q2 24 | $491.8M | — |
总资产CTOKMTS
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $246.7M | ||
| Q3 25 | $1.2B | $266.3M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.0B | — |
负债/权益比CTOKMTS
| Q1 26 | — | — | ||
| Q4 25 | 1.09× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | 0.85× | — | ||
| Q3 24 | 0.88× | — | ||
| Q2 24 | 0.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-18.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-25.6M |
| 自由现金流率自由现金流/营收 | — | -113.5% |
| 资本支出强度资本支出/营收 | — | 32.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CTOKMTS
| Q1 26 | — | — | ||
| Q4 25 | $64.6M | $-18.3M | ||
| Q3 25 | $25.5M | $-26.3M | ||
| Q2 25 | $21.9M | — | ||
| Q1 25 | $10.3M | — | ||
| Q4 24 | $59.9M | — | ||
| Q3 24 | $21.2M | — | ||
| Q2 24 | $12.9M | — |
自由现金流CTOKMTS
| Q1 26 | — | — | ||
| Q4 25 | — | $-25.6M | ||
| Q3 25 | — | $-34.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率CTOKMTS
| Q1 26 | — | — | ||
| Q4 25 | — | -113.5% | ||
| Q3 25 | — | -177.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度CTOKMTS
| Q1 26 | — | — | ||
| Q4 25 | — | 32.2% | ||
| Q3 25 | — | 42.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率CTOKMTS
| Q1 26 | — | — | ||
| Q4 25 | 2.28× | — | ||
| Q3 25 | 8.75× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 4.56× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | 10.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
